Identification of a human epithelial cell surface protein sharing an epitope with the C3d/epstein‐barr virus receptor molecule of B lymphocytes

This work examines the basis for our earlier observation that certain monoclonal antibodies (MAbs) specific for the B‐cell‐associated C3d/Epstein‐Barr virus (EBV) receptor molecule CD21 also react with the surface of some epithelial cells. Of 9 proven anti‐CD21 MAbs now examined on frozen sections of human nasopharynx, tonsil and ecto‐cervix, only 3 (HB5, anti‐B2, AB1) showed staining of stratified epithelium; 2 of these (HB5, anti‐B2) also reacted with the surface of epithelial cells freshly dispersed from these sites. The proportion of HB5‐ and anti‐B2‐reactive cells in primary epithelial cultures fell to a low but stable level within days of explantation, while almost all permanently established epithelial cell lines, whether SV40 virus‐transformed or of malignant origin, were not reactive with either MAb. This contrasts with the pattern of expression of another surface marker also found selectively on cells of the lymphoid and epithelioid lineages, the CDw40 antigen. Staining with CDw40 MAbs on epithelial sections was usually restricted to the basal (proliferating) layer, but the proportion of CDw40‐positive cells increased to a relatively high level in normal epithelial cultures; furthermore, most epithelial cell lines expressed this antigen. Immunoprecipitation from the surface of metabolically labelled epithelial cells with the anti‐CD21 MAb HB5 yielded a protein of approximate MW 200 kDa, clearly different in size from the 145 kDa CD21 molecule on B cells. This 200 kDa protein was identified on fresh ecto‐cervical epithelium, on primary cultures of a laryngeal carcinoma and on one unusual SV40‐transformed epithelial cell line. We conclude that stratified human epithelial cells express a 200 kDa surface molecule which is antigenically related to, but not identical with, the CD21 antigen on B cells. It remains to be seen whether this epithelial cell protein can function as an EBV receptor.

[1]  N. Miller,et al.  A monoclonal antibody to glycoprotein gp85 inhibits fusion but not attachment of Epstein-Barr virus , 1988, Journal of virology.

[2]  J. Fingeroth,et al.  Characterization of a T-lymphocyte Epstein-Barr virus/C3d receptor (CD21) , 1988, Journal of virology.

[3]  G. Guy,et al.  Resting B lymphocytes can be triggered directly through the CDw40 (Bp50) antigen. A comparison with IL-4-mediated signaling. , 1988, Journal of immunology.

[4]  D. Fearon,et al.  Structure of the human B lymphocyte receptor for C3d and the Epstein- Barr virus and relatedness to other members of the family of C3/C4 binding proteins [published erratum appears in J Exp Med 1988 Nov 1;168(5):1953-4] , 1988, The Journal of experimental medicine.

[5]  G. Nemerow,et al.  Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[6]  E. Kieff,et al.  Epstein-barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis , 1987, Cell.

[7]  G. Nemerow,et al.  Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d , 1987, Journal of virology.

[8]  T. Fujita,et al.  Functional and antigenic properties of complement receptor type 2, CR2 , 1987, The Journal of experimental medicine.

[9]  L. Young,et al.  Human epithelial cell expression of an Epstein-Barr virus receptor. , 1987, The Journal of general virology.

[10]  D. Fearon,et al.  Identification of a partial cDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: homology with the receptor for fragments C3b and C4b of the third and fourth components of complement. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[11]  E. Clark,et al.  Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[12]  L. Young,et al.  EPSTEIN-BARR VIRUS RECEPTORS ON HUMAN PHARYNGEAL EPITHELIA , 1986, The Lancet.

[13]  E. Lennette,et al.  Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion. , 1985, The New England journal of medicine.

[14]  J. Platt,et al.  Monoclonal antibodies to the 140,000 mol wt glycoprotein of B lymphocyte membranes (CR2 receptor) initiates proliferation of B cells in vitro. , 1985, Blood.

[15]  T. Schulz,et al.  Growth control of activated, synchronized murine B cells by the C3d fragment of human complement , 1985, Nature.

[16]  M. Ng,et al.  A SHARED ANTIGENIC DETERMINANT BETWEEN HUMAN B LYMPHOCYTES AND CARCINOMAS (BLCa) , 1985, International journal of cancer.

[17]  G. Nemerow,et al.  Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2) , 1985, Journal of virology.

[18]  R. Schlegel,et al.  Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. , 1985, The American journal of pathology.

[19]  M. Epstein,et al.  Distinctions between endemic and sporadic forms of epstein‐barr virus‐positive burkitt's lymphoma , 1985, International journal of cancer.

[20]  Wolfgang Mayer,et al.  Structure and transcription of human papillomavirus sequences in cervical carcinoma cells , 1985, Nature.

[21]  M. Cooper,et al.  Expression of C3d receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody. , 1984, Journal of immunology.

[22]  N. Raab-Traub,et al.  Epstein-Barr virus replication in oropharyngeal epithelial cells. , 1984, The New England journal of medicine.

[23]  E. Parkinson,et al.  Extracellular matrix components produced by SV40‐transformed human epidermal keratinocytes , 1984, International journal of cancer.

[24]  D. Schmitt,et al.  An anti-lymphocyte monoclonal antibody (HB8) which cross reacts with human dermal elastic fibers. , 1984, Immunology letters.

[25]  H. Lassmann,et al.  A shared antigenic determinant between natural killer cells and nervous tissue , 1983, Nature.

[26]  S. Povey,et al.  Identity of some human bladder cancer cell lines , 1983, Nature.

[27]  P. Grabham,et al.  A subpopulation of cultured human keratinocytes which is resistant to the induction of terminal differentiation-related changes by phorbol, 12-myristate, 13-acetate: evidence for an increase in the resistant population following transformation. , 1983, Carcinogenesis.

[28]  E J Holborow,et al.  Fading of immunofluorescence during microscopy: a study of the phenomenon and its remedy. , 1982, Journal of immunological methods.

[29]  M. Greaves,et al.  Monoclonal antibodies defining markers with apparent selectivity for particular haemopoietic cell types may also detect antigens on cells of neural crest origin. , 1982, Hybridoma.

[30]  L. Nadler,et al.  Characterization of a human B cell-specific antigen (B2) distinct from B1. , 1981, Journal of immunology.

[31]  J. Rheinwald,et al.  Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas. , 1981, Cancer research.

[32]  T. Lebien,et al.  A monoclonal antibody (BA-1) reactive with cells of human B lymphocyte lineage. , 1981, Journal of immunology.

[33]  J. Rheinwald.  Chapter 15 Serial Cultivation of Normal Human Epidermal Keratinocytes , 1980 .

[34]  M. Epstein,et al.  The Epstein-Barr Virus , 1979, Springer Berlin Heidelberg.

[35]  C. Barnstable,et al.  Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis , 1978, Cell.

[36]  S. Lemon,et al.  Replication of EBV in epithelial cells during infectious mononucleosis , 1977, Nature.

[37]  J. H. Pope,et al.  Transformation of foetal human leukocytes in vitro by filtrates of a human leukaemic cell line containing herpes‐like virus , 1968 .

[38]  V. Diehl,et al.  Herpes-Type Virus and Chromosome Marker in Normal Leukocytes after Growth with Irradiated Burkitt Cells , 1967, Science.

[39]  G. Moore,et al.  Studies of a human tumor cell line with a diploid karyotype , 1964, Cancer.